Teaching the Immune System to Fight Cancer
Update: 2025-08-22
Description
Antibody-drug conjugates (ADCs) are a relatively new type of medicine for breast cancer. Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) and Dato-DXd (brand name: Datroway) are two ADCs used to treat breast cancer.
Dr Benjamin Schrank and colleagues have developed a new type of ADC that combines an antibody with a toxin — called an antibody-toxin conjugate — that teaches the immune system to recognize and attack cancer cells.
Listen to the episode to hear Dr. Schrank explain:
- the antibody and the toxin component of the medicine
- how the new medicine works
- possible side effects
- next steps for the research
Episode image photo credit: The University of Texas MD Anderson Cancer Center
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
